Haemovigilance (HV) comprises surveillance procedures covering the whole transfusion chain from collection of blood (components) to follow-up of its recipients. It assesses information on undesirable transfusion effects to prevent their occurrence. This includes local venepuncture accidents, iron depletion, graft vs. host disease and mild to severe transfusion reactions. The HV definitions aim to standardize and report all these events in order to improve blood safety.

 

Current Leadership

Mary Townsend

Mary Townsend

Haemovigilance Working Party Chair, Senior Medical Director, Vitalant, Phoenix, Arizona, US

Gopal Patidar

Gopal Patidar

Haemovigilance Working Party Secretary, Associate Professor, Department of Transfusion Medicine, AIIMS, New Delhi, India